These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

562 related items for PubMed ID: 25577263

  • 1. Perspectives on osteoporosis therapies.
    Cairoli E, Zhukouskaya VV, Eller-Vainicher C, Chiodini I.
    J Endocrinol Invest; 2015 Mar; 38(3):303-11. PubMed ID: 25577263
    [Abstract] [Full Text] [Related]

  • 2. Osteoporosis: now and the future.
    Rachner TD, Khosla S, Hofbauer LC.
    Lancet; 2011 Apr 09; 377(9773):1276-87. PubMed ID: 21450337
    [Abstract] [Full Text] [Related]

  • 3. The future of osteoporosis treatment - a research update.
    Lippuner K.
    Swiss Med Wkly; 2012 Apr 09; 142():w13624. PubMed ID: 22815185
    [Abstract] [Full Text] [Related]

  • 4. A new antiresorptive approach to the treatment of fragility fractures: long-term efficacy and safety of denosumab.
    Tarantino U, Celi M, Feola M, Liuni FM, Resmini G, Iolascon G.
    Aging Clin Exp Res; 2013 Oct 09; 25 Suppl 1():S65-9. PubMed ID: 24046047
    [Abstract] [Full Text] [Related]

  • 5. Targeted inhibition of sclerostin for post-menopausal osteoporosis therapy: A critical assessment of the mechanism of action.
    Bhattacharyya S, Pal S, Chattopadhyay N.
    Eur J Pharmacol; 2018 May 05; 826():39-47. PubMed ID: 29476877
    [Abstract] [Full Text] [Related]

  • 6. Anti-sclerostin antibodies: utility in treatment of osteoporosis.
    Clarke BL.
    Maturitas; 2014 Jul 05; 78(3):199-204. PubMed ID: 24842796
    [Abstract] [Full Text] [Related]

  • 7. Potential new drug targets for osteoporosis.
    Deal C.
    Nat Clin Pract Rheumatol; 2009 Jan 05; 5(1):20-7. PubMed ID: 19098925
    [Abstract] [Full Text] [Related]

  • 8. New therapeutic targets for osteoporosis: beyond denosumab.
    Lim V, Clarke BL.
    Maturitas; 2012 Nov 05; 73(3):269-72. PubMed ID: 22925430
    [Abstract] [Full Text] [Related]

  • 9. Appropriate models for novel osteoporosis drug discovery and future perspectives.
    Gennari L, Rotatori S, Bianciardi S, Gonnelli S, Nuti R, Merlotti D.
    Expert Opin Drug Discov; 2015 Nov 05; 10(11):1201-16. PubMed ID: 26292627
    [Abstract] [Full Text] [Related]

  • 10. Management of postmenopausal osteoporosis and the prevention of fractures.
    Gambacciani M, Levancini M.
    Panminerva Med; 2014 Jun 05; 56(2):115-31. PubMed ID: 24942322
    [Abstract] [Full Text] [Related]

  • 11. Established and forthcoming drugs for the treatment of osteoporosis.
    Lems WF, den Heijer M.
    Neth J Med; 2013 May 05; 71(4):188-93. PubMed ID: 23723112
    [Abstract] [Full Text] [Related]

  • 12. [Mechanisms of action of anticatabolic drugs used in osteoporosis therapy].
    Kryśkiewicz E, Lorenc RS.
    Endokrynol Pol; 2009 May 05; 60(2):134-44. PubMed ID: 19396757
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological Treatment of Bone Loss.
    Pang R, Xia W.
    Curr Pharm Des; 2017 May 05; 23(41):6298-6301. PubMed ID: 28521692
    [Abstract] [Full Text] [Related]

  • 14. Romosozumab for the treatment of osteoporosis.
    Bandeira L, Lewiecki EM, Bilezikian JP.
    Expert Opin Biol Ther; 2017 Feb 05; 17(2):255-263. PubMed ID: 28064540
    [Abstract] [Full Text] [Related]

  • 15. Bi-directionally selective bone targeting delivery for anabolic and antiresorptive drugs: a novel combined therapy for osteoporosis?
    Liu J, Zhang H, Dong Y, Jin Y, Hu X, Cai K, Ma J, Wu G.
    Med Hypotheses; 2014 Dec 05; 83(6):694-6. PubMed ID: 25459136
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical effects of bisphosphonates in involutional osteoporosis.
    Ott SM.
    J Bone Miner Res; 1993 Dec 05; 8 Suppl 2():S597-606. PubMed ID: 8122531
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Osteoporosis: From Molecular Mechanisms to Therapies 2.0.
    Tang CH.
    Int J Mol Sci; 2020 Oct 28; 21(21):. PubMed ID: 33126410
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms of action of antiresorptive therapies of postmenopausal osteoporosis.
    Stepan JJ, Alenfeld F, Boivin G, Feyen JH, Lakatos P.
    Endocr Regul; 2003 Dec 28; 37(4):225-38. PubMed ID: 15106819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.